Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia is a common hair loss condition caused by testosterone effects on hair follicles, leading to thinner, shorter, and less pigmented hair, diagnosed using scalp dermoscopy and treated with topical minoxidil, antiandrogen agents, and 5-alpha reductase inhibitors.

Men and women have different hairline restoration needs, with natural design being more complex for women, and hairline changes being important for transgender individuals' transitions.

A new tool makes hair transplant surgeries faster by creating multiple cuts in one go.

Hair enzyme activity predicts minoxidil success in Brazilian women with hair loss.

The document concludes that early and accurate diagnosis of hair loss on the top of the scalp in Black men is important to distinguish CCCA from other types of hair loss.

Most older adults experience pattern hair loss due to shrinking hair follicles, with men and women showing different balding patterns.

A man's scalp condition was misidentified as hair loss dots but was actually a common follicular disorder.

Minoxidil effectively improved hair loss in a teenage girl with androgenetic alopecia.

The 16-year-old girl with hair loss was successfully treated for alopecia areata, leading to significant hair regrowth.

Male pattern baldness is a genetic condition causing hair loss, with limited but improving treatment options.

The conclusion is that detailed clinical descriptions help pathologists diagnose hair loss conditions more accurately.

Minoxidil and finasteride are the only FDA-approved treatments for hair loss caused by genetic and hormonal factors, but their effectiveness is often doubted, indicating a need for new treatments.

Androgenetic alopecia is a common type of hair loss in men and women, caused by a testosterone byproduct affecting hair follicles, with sensitivity determined by genetics.

Dutasteride mesotherapy showed mixed results and is not recommended as a primary treatment for hair loss.

Erosive pustular dermatosis of the scalp causes painful, scarring skin lesions on the scalp, mainly in elderly people with sun-damaged skin.

The BASP classification is a detailed system for categorizing hair loss in both men and women, but it may be complex for beginners and not fully suitable for grading female hair loss.

Minoxidil foam promotes hair growth and reduces hair loss safely in men.

Early balding, premature graying, and hair thinning can predict heart disease in young Asian males.

Injecting platelet-rich plasma into the scalp stimulates hair growth, increases hair density, and treats hair loss effectively with minimal side effects.

Platelet-rich plasma (PRP) injections effectively treat hair loss and thinning in both men and women, with high satisfaction and no major side effects.

Minoxidil foam 5% effectively treats hair loss in both frontal and vertex scalp regions.

Minoxidil foam effectively promotes hair growth and reduces hair loss in men.

Increased PPARGC1α relates to hair thinning in common baldness.

Women with thinning hair have thinner hair strands than women without hair loss.

Severe vertex pattern hair loss may indicate a higher risk for artery plaque buildup.

Treat the front and middle scalp before the vertex in hair transplants, aim for good density, use non-surgical options for young people, and customize treatment for natural results.

Aging in hair follicle stem cells leads to hair graying, thinning, and loss.

The supplement helps improve hair growth and reduce hair shedding.

Minoxidil can increase hair density, speed up regrowth in transplanted hair, and slow down further hair loss, especially beneficial for women, young men with thinning hair, and those wanting to reconstruct the back of the scalp.

Male pattern baldness, especially the vertex type, could be an early sign of cardiovascular risk factors like high cholesterol and diabetes.